0.5073
Kala Bio Inc Borsa (KALA) Ultime notizie
KALA (KALA) Technicals: Moves 6.67% Down to $0.84; Technical Setup: the Supplied Trading Band Runs From $0.80 to $0.88 at the CloseProtective Put - vinanet.vn
KALA Stock Hits Record Low – Firm Announces Reverse Split After Shares Fail To Surpass The $1 Mark - Stocktwits
KALA BIO: Q2 Earnings Snapshot - AOL.com
KALA BIO Q2 Net Loss Narrows to $1.58 Million Amid Sharp Spending Cuts - Minichart
KALA BIO, Inc. Q2 2026: Net loss $(1.58M), EPS $(21.32) — 10-Q Summary - TradingView
KALA: Net loss narrowed sharply as focus shifted to AI platform, with liquidity supported by note receivable - TradingView
KALA BIO (KALA) pivots to biotech AI with $229K on hand - Stock Titan
KALA (KALA) Session: Retreats 0.97% to $0.89; Next Session: Price Remains Between $0.85 Support and $0.93 Resistance in the Latest ReadingRTH Profile - vinanet.vn
KALA Q4 2025 Earnings: Loss Narrows to -33.5 Per Share, Beating Estimates by 54.38Performance Review - vinanet.vn
KALA BIO Announces Brief Delay in Quarterly Filing - TipRanks
KALA BIO (KALA) delays June 30, 2026 Form 10-Q to finalize liquidity analysis - Stock Titan
KALA Q4 2025 Earnings: Narrower-Than-Expected Loss Delivers a 54.38 EPS SurpriseDividend Growth Analysis - vinanet.vn
KALA BIO Inc (KALA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
KALA BIO (KALA) Climbs 4.4% to $0.73 as Bulls Target $0.77 ResistanceRevenue Weighted - Vinanet
KALA Q2'26 Earnings: EPS estimate is (6.00) USD - TradingView
KALA BIO Inc. (KALA) Gains 3.59% to $0.76 — Approaches Key Resistance at $0.80Systematic Flow - vinanet.vn
KALA BIO Inc (KALA) Institutional Confidence - TradingKey
KALA Q2'26 Earnings: revenue estimate is 0 USD - TradingView
KALA BIO Inc (KALA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
KALA BIO Inc (KALA) Cash Flow - TradingKey
KALA BIO Inc (KALA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
KALA BIO Inc (KALA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
KALA Q4 2025 Earnings: Significant Beat on EPS Despite No Reported RevenueRevenue Inflection Point - vinanet.vn
TradingKey - TradingKey
KALA BIO Inc (KALA) Balance Sheet - TradingKey
KALA|KALA BIO Inc|Price:0.740|Chg%:-0.003 - TradingKey
KALA|KALA BIO Inc|Price:0.671|Chg%:+0.036 - TradingKey
KALA BIO, Inc. Revenue Breakdown – NASDAQ:KALA - TradingView
KALA|KALA BIO Inc|Price:0.634|Chg%:+0.024 - TradingKey
KALA BIO Inc (KALA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Kala Bio, Inc. Files Form 8-K with SEC Detailing Nasdaq Listing and Corporate Information - Minichart
KALA Q4 2025 Earnings: EPS Beat Masks Revenue Woes as Stock Slides 17%Financial Data - vinanet.vn
Kala Bio Files ATM Offering Of Up To $250 Million In Common StockSEC Filing - TradingView
Frontier tech research, news & data - MLQ.ai
KALA BIO Shares Plunge Over 7% as Stock Nears Critical Support LevelGamma Flip Level - vinanet.vn
Kala Bio announces 1-for-50 reverse stock split effective Friday - Investing.com
Form 13D/A KALA BIO For: 2 July By Investing.com - Investing.com Nigeria
David Lazar trims KALA BIO (KALA) stake to 3.9% with 719,404 shares - Stock Titan
Price to earnings forward of KALA BIO, Inc. – NASDAQ:KALA - TradingView
KALA BIO Inc. (KALA) Holds Near Support After Slight Decline: Key Levels in FocusVanna Flow - dars.gov.et
[EFFECT] KALA BIO, Inc. SEC Filing - Stock Titan
Enterprise value to EBIT forward of KALA BIO, Inc. – NASDAQ:KALA - TradingView
Enterprise value to EBITDA forward of KALA BIO, Inc. – NASDAQ:KALA - TradingView
Price to book forward of KALA BIO, Inc. – NASDAQ:KALA - TradingView
Enterprise value to revenue forward of KALA BIO, Inc. – NASDAQ:KALA - TradingView
KALA Q4 2025 Earnings: EPS Beats Estimates, Stock Surges 26.9%Slow Growth Warning - dars.gov.et
KALA BIO StockLong-term eye-disease strategy in focus - AD HOC NEWS
KALA BIO Inc (KALA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):